🇺🇸 CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases

🇺🇸 Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared MELBOURNE, Australia and BASEL, Switzerland, Oct. 4, 2026 /PRNewswire/ — CSL and Alentis Therapeutics today announced they have entered into an exclusive global… Source: prnewswire Country: United States

🇺🇸 Alexy Metals Named to 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

🇺🇸 Northeast Ohio brazing alloy manufacturer and precious-metal refiner ranks No. 2,580 nationally following 125% three-year revenue growth WILLOUGHBY, Ohio, Oct. 4, 2026 /PRNewswire/ — Alexy Metals, a Northeast Ohio manufacturer specializing in brazing alloys, precision preforms and… Source: prnewswire Country: United States

🇺🇸 24 HOUR BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

🇺🇸 SAN DIEGO, Oct. 4, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Alibaba Group Holding Limited (NYSE: BABA) publicly traded securities between June 26, 2025 and June 24, 2026, inclusive (the “Class Period”), have until tomorrow, Monday,… Source: prnewswire Country: United States

🇺🇸 SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

🇺🇸 MILAN, Oct. 4, 2026 /PRNewswire/ — At the European Association for the Study of Diabetes (EASD) 2026, SiBionics presented “See More, Act Earlier,” connecting continuous sensing with future diabetes care. Three exhibition chapters shaped this vision: “See More: Beyond Glucose,” covering… Source: prnewswire Country: United States

🇺🇸 BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

🇺🇸 NEW YORK, Oct. 3, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026… Source: prnewswire Country: United States

🇺🇸 Снижение массы тела на 19,3 % к 48-й неделе — данные исследования фазы III препарата Olatorepatide, двойного селективного агониста ГПП-1/ГИП компании Hansoh, представлены на EASD

🇺🇸 МИЛАН, 3 октября 2026 г. /PRNewswire/ — С 28 сентября по 2 октября 2026 года в Милане, Италия, проходит ежегодная конференция ассоциации European Association for the Study of Diabetes (EASD). Разработанный компанией Hansoh Pharma двойной селективный агонист рецепторов глюкагоноподобного… Source: prnewswire Country: United States